| 产品详情 |
| Edit |   |
|---|
| Product Name | Recombinant Human LIF R alpha (Mammalian-expressed), CF |
|---|
| Description | Purity >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining. MW (observed): 110-140 kDa, reducing conditions. MW (theoretical): 89.4 kDa. The Recombinant Human LIF R alpha (Mammalian-expressed) from R&D Systems is derived from HEK293. The Recombinant Human LIF R alpha (Mammalian-expressed) has been validated for the following applications: Bioactivity. |
|---|
| Size | 50 ug |
|---|
| Concentration | n/a |
|---|
| Applications | Bioactivity |
|---|
| Other Names | CD118, CD118 antigen, FLJ98106, FLJ99923, leukemia inhibitory factor receptor, leukemia inhibitory factor receptor alpha, LIF R beta, LIF receptor, LIFR, LIF-R, LIFRa, SJS2, STWS, SWS |
|---|
| Gene, Accession, CAS # | LIFR, Gene ID: 3977, Accession: NP_001121143 |
|---|
| Catalog # | 7487-LR-050 |
|---|
| Price | |
|---|
| Order / More Info | Recombinant Human LIF R alpha (Mammalian-expressed), CF from R&D SYSTEMS, INC. |
|---|
| Product Specific References | PubMed: 25915540 |
|---|
| 产品资料 |
|
|